In the News

Southern Research Receives $7.5 Million Award to Discover New Therapies for Cystic Fibrosis Patients with Rare Mutations

by Traci Bratton

October 22, 2015
Print
Email

In addition, through the Alabama Drug Discovery Alliance (ADDA), Southern Research and UAB established a program to look for potential new treatments for several rare genetic diseases such as Hurler's syndrome, with mutations similar to those found in some CF patients.

http://www.bloomberg.com/research/markets/news/article.asp?docKey=600-201510210930PR_NEWS_USPRX____DC33889-1

back to top

Media Policy Guidelines

Marketing and Communications

UAB Home

The University of Alabama at Birmingham

1720 2nd Ave South

Birmingham, AL 35294

Public Relations: (205) 934-3884

Media Specialist On Call: (205) 934-3411

Contact UAB
|
|
A-Z Site Index
|
Privacy
|
Terms of Use
|

UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.